Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy

NCT01428635 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Primary Myelofibrosis
Thrombocytopenia

Interventions

DRUG: Eltrombopag Olamine

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]